LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too ...

Caption: Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said she believed the 'greatest good' right now can be achieved by allowing some Americans who are ...

Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.

Sudbury's Ashley Gibson-Taylor says she was "absolutely thrilled" when she heard Pfizer-BioNTech's vaccine for children aged five to 11 will start to arrive in Canada on Sunday. Gibson-Taylor has two ...

Social media claims linking Pfizer’s Covid-19 vaccine to hantavirus infection are misleading. A fact-check shows that the ...

Hantavirus pulmonary infection is a disease caused by some hantaviruses, not the Pfizer-BioNTech COVID-19 vaccine, contrary ...

BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) granted temporary authorization on 2 December to Pfizer and BioNTech’s mRNA-based BNT162b2 COVID-19 vaccine, vaulting ahead of ...